BE904922A - Procedes de traitement de troubles gastro-intestinaux infectieux. - Google Patents

Procedes de traitement de troubles gastro-intestinaux infectieux.

Info

Publication number
BE904922A
BE904922A BE0/216783A BE216783A BE904922A BE 904922 A BE904922 A BE 904922A BE 0/216783 A BE0/216783 A BE 0/216783A BE 216783 A BE216783 A BE 216783A BE 904922 A BE904922 A BE 904922A
Authority
BE
Belgium
Prior art keywords
methods
gastrointestinal disorders
treating infectious
infectious gastrointestinal
subject
Prior art date
Application number
BE0/216783A
Other languages
English (en)
Original Assignee
Marshall Barry J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24994180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE904922(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Marshall Barry J filed Critical Marshall Barry J
Publication of BE904922A publication Critical patent/BE904922A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Procédé pour le traitement d'un etre humain ou d'un animal inférieur souffrant d'un trouble gastro-intestinal infectieux, caractérise en ce qu'il comprend l'administration au sujet en question d'environ 50mg à environ 5000g de bismuth par jour, pendant 3 à 56 jours.
BE0/216783A 1985-06-13 1986-06-13 Procedes de traitement de troubles gastro-intestinaux infectieux. BE904922A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74484285A 1985-06-13 1985-06-13

Publications (1)

Publication Number Publication Date
BE904922A true BE904922A (fr) 1986-12-15

Family

ID=24994180

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216783A BE904922A (fr) 1985-06-13 1986-06-13 Procedes de traitement de troubles gastro-intestinaux infectieux.

Country Status (8)

Country Link
US (1) US5601848A (fr)
EP (2) EP0206626B2 (fr)
JP (1) JPH0794391B2 (fr)
AT (2) ATE79264T1 (fr)
BE (1) BE904922A (fr)
DE (4) DE3686362T2 (fr)
IE (2) IE59585B1 (fr)
PH (1) PH26891A (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
EP0348143A3 (fr) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Dérivés de bismuth de phosphates et sulphates de saccharides
EP0363502B1 (fr) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Formulation liquide contenant du bismuth, procédé pour la préparer et son utilisation
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
JPH06508641A (ja) * 1992-04-10 1994-09-29 フセソユズニ　ナウチノ−イススレドバテルスキ　インスティテュト　メディツィンスキフ　ポリメロフ 医薬組成物
US5376553A (en) * 1993-06-18 1994-12-27 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
WO1995008332A1 (fr) * 1993-09-20 1995-03-30 The Procter & Gamble Company Utilisation de phosphates de triclosan dans le traitement de troubles gastrointestinaux dus a l'infection a heliobacter
WO1995012579A1 (fr) * 1993-11-05 1995-05-11 Otsuka Pharmaceutical Company, Limited Sel de bismuth de derives de carbostyrile destines au traitement des ulceres gastro-duodenaux
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5607964A (en) * 1994-06-17 1997-03-04 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
BR9611913A (pt) * 1995-12-07 1999-03-02 Procter & Gamble Composições contendo bismuto para a prevenção e tratamento de distúrbios gastrintestinais
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
GB9623962D0 (en) * 1996-11-15 1997-01-08 Tillotts Pharma Ag Pharmaceutical composition
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
USRE38728E1 (en) * 1997-09-11 2005-04-19 Oridion Medical, LTD Breath test analyzer
US7008777B2 (en) * 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US20030073155A1 (en) * 2001-10-15 2003-04-17 Mcmichael Donald J. Methods for performing multiple diagnostic tests
US6929926B2 (en) 2001-10-15 2005-08-16 Barry J. Marshall Composition for the detection of gastrointestinal disorders
US20030072686A1 (en) * 2001-10-15 2003-04-17 Marshall Barry J. Systems for performing multiple diagnostic tests
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing
US20040086532A1 (en) * 2002-11-05 2004-05-06 Allergan, Inc., Botulinum toxin formulations for oral administration
WO2007090113A2 (fr) 2006-02-01 2007-08-09 Weg Stuart L Utilisation de compositions antifongiques pour traiter des conditions gastro-intestinales superieures
FR2913403B1 (fr) 2007-03-05 2009-05-29 Astrium Sas Soc Par Actions Si Commande d'actionneur reduisant le niveau de vibrations d'une structure flexible associee
WO2013096512A1 (fr) * 2011-12-20 2013-06-27 Gilead Sciences, Inc. Compositions pharmaceutiques et procédés pour le traitement d'infections et troubles gastro-intestinaux

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301743A (fr) * 1962-12-13
FR4961M (fr) * 1965-03-29 1967-04-03
FR5877M (fr) * 1966-07-22 1968-03-18
FR6197M (fr) * 1967-04-12 1968-07-22
US3577533A (en) * 1968-02-21 1971-05-04 Joseph Alfred Rider Antacid compositions containing bismuth aluminate and coprecipitated aluminum hydroxide and magnesium carbonate
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
DE1963496A1 (de) * 1969-12-18 1971-06-24 Hans Voigt Chemisch Pharmazeut Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen
US4118480A (en) * 1973-02-09 1978-10-03 Charles V. Stoelker Pharmaceutical preparation for treating hemorrhoids and anal fissures
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof

Also Published As

Publication number Publication date
IE59584B1 (en) 1994-03-09
DE3686362T2 (de) 1993-02-11
EP0206626A3 (en) 1989-04-12
EP0206627A2 (fr) 1986-12-30
DE3686361T2 (de) 1993-02-11
JPS6248624A (ja) 1987-03-03
DE3686361T3 (de) 2003-01-09
EP0206626B2 (fr) 2002-05-22
DE3619733A1 (de) 1987-02-12
ATE79264T1 (de) 1992-08-15
EP0206627A3 (en) 1989-04-05
IE861573L (en) 1986-12-13
DE3686361D1 (de) 1992-09-17
PH26891A (en) 1992-11-03
IE861574L (en) 1986-12-13
EP0206627B1 (fr) 1992-08-12
US5601848A (en) 1997-02-11
EP0206626B1 (fr) 1992-08-12
JPH0794391B2 (ja) 1995-10-11
IE59585B1 (en) 1994-03-09
EP0206626A2 (fr) 1986-12-30
ATE79261T1 (de) 1992-08-15
DE3619734A1 (de) 1987-02-12
DE3686362D1 (de) 1992-09-17

Similar Documents

Publication Publication Date Title
BE904922A (fr) Procedes de traitement de troubles gastro-intestinaux infectieux.
Brady Some views on effective principles of psychotherapy.
FR2692037B1 (fr) Procede de diagnostic d'un processus evolutif.
KR0125921B1 (en) Method and device for the diagnosis and treatment of nasal diseases
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
IT1151636B (it) Metodo e sistema per il trattamento extracorporeo del sangue
OA08621A (fr) Procédé et installation de traitement à l'anmoniac.
DE3681883D1 (de) System zum sammeln, behandeln und zurueckfuehren des blutes eines patienten.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
FR2701380B1 (fr) Dispositif de traitement de signaux biologiques prélevés par des électrodes sur la peau d'un patient.
DE58908452D1 (de) Medizinisches Gerät zur Diagnose und/oder Therapie.
DE3855527D1 (de) Doppelsträngige RNS zur Korrektur von Abnormalitäten von zirkulierenden Immunkomplexen und der Monozytenfunktion
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
DE69310281D1 (de) Medizinisches Diagnosegerät zur Erkennung von Erkrankungen des Gehirns
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
ATE65413T1 (de) Geraet zur aussenkoerperlichen behandlung von koerperlichen fluessigkeiten.
EP0201591A4 (fr) Methode de developpement de produits pharmaceutiques pour le traitement d'affections.
NO880292D0 (no) Fremgangsmaate for behandling av humle.
AU8054887A (en) An improved method
EP0495998A4 (fr)
EP0286802A3 (fr) Emploi de l'ofloxacine pour le traitement ou la prophylaxie topique des troubles péridontiques
FR2492262B1 (fr) Procede et dispositif de commande d'un appareil ou instrument notamment un stimulateur cardiaque implantable

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *MARSHALL BARRY J.

Effective date: 20060613